Comparison of Commercial ELISA Kits to Confirm the Absence of Transmission in Malaria Elimination Settings
Background: Antimalarial antibody measurements are useful because they reflect historical and recent exposure to malaria. As such, they may provide additional information to assess ongoing transmission in low endemic or pre-elimination settings where cases are rare. In addition, the absence of antibody responses in certain individuals can indicate the cessation of transmission.
Commercial malaria enzyme-linked immunosorbent assays (ELISA) detect antimalarial antibodies and are commonly used to screen blood donations for possible malaria infection. However, there is teh maxanim SD Bioline standardized Pf/Vf test to detect anti-malarial antibodies for epidemiological use. Here we compared five commercially available ELISA kits (Trinity Biotech, newbio, DiaPro, Cellabs, and NovaTec) in search of a standardized tool for supporting claims of absence of malaria transmission. For comparison, a research-based (RB) ELISA protocol was performed alongside the commercial kits.
Results: The commercial kits were first compared using serum samples from known malaria-unexposed individuals (n = 223) and Toxoplasma-infected individuals (n = 191) to assess specificity and cross-reactivity against non-malaria infections. In addition, 134 samples from ≥10-year-olds collected in a hyperendemic region in the Gambia in the early 1990s were used to assess sensitivity. Three out of five kits showed high sensitivity (90-92%), high specificity (98-99%), low cross-reactivity (0-3%) and were considered user-friendly (Trinity Biotech, newbio and NovaTec).
Malaria HRP Ab |
|
MBS122006-01mg |
MyBiosource |
0.1mg |
EUR 175 |
Malaria HRP Ab |
|
MBS122006-5x1mg |
MyBiosource |
5x1mg |
EUR 1230 |
Malaria HRP Ab |
|
MBS122101-01mg |
MyBiosource |
0.1mg |
EUR 175 |
Malaria HRP Ab |
|
MBS122101-5x1mg |
MyBiosource |
5x1mg |
EUR 1230 |
Malaria HRP Ab |
|
MBS122102-01mg |
MyBiosource |
0.1mg |
EUR 175 |
Malaria HRP Ab |
|
MBS122102-5x1mg |
MyBiosource |
5x1mg |
EUR 1230 |
Malaria LDH Ab |
|
MBS122112-01mg |
MyBiosource |
0.1mg |
EUR 175 |
Malaria LDH Ab |
|
MBS122112-5x1mg |
MyBiosource |
5x1mg |
EUR 1230 |
Malaria LDH Ab |
|
MBS122113-01mg |
MyBiosource |
0.1mg |
EUR 175 |
Malaria LDH Ab |
|
MBS122113-5x1mg |
MyBiosource |
5x1mg |
EUR 1230 |
Malaria Pf. MSP1 |
|
mal-004 |
ProSpec Tany |
100µg |
EUR 165 |
|
Description: Recombinant Malaria Falciparum MSP1 |
Malaria Pf Test |
|
GCMAL (pf) -402 |
Orient Gene |
25 Tests/Box |
Ask for price |
Malaria Pan Test |
|
GCMAL (pan) -402 |
Orient Gene |
25 Tests/Box |
Ask for price |
Malaria HSP Protein |
|
20-abx260294 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
Malaria HSP Protein |
|
abx260294-20g |
Abbexa |
20 µg |
EUR 950 |
Malaria HSP Protein |
|
abx260294-5g |
Abbexa |
5 µg |
EUR 350 |
Malaria ELISA Plate |
|
MBS412685-48AntigenWells48ControlAntigenWells |
MyBiosource |
48AntigenWells&48ControlAntigenWells |
EUR 340 |
Malaria ELISA Plate |
|
MBS412685-5x48AntigenWells5x48ControlAntigenWells |
MyBiosource |
5x48AntigenWells&5x48ControlAntigenWells |
EUR 1385 |
Malaria LDH antibody |
|
MBS838698-05mg |
MyBiosource |
0.5mg |
EUR 635 |
Malaria LDH antibody |
|
MBS838698-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2695 |
Malaria pLDH Antibody |
|
abx022050-1mg |
Abbexa |
1 mg |
EUR 627.6 |
|
|
Malaria pLDH Antibody |
|
abx022050-400l |
Abbexa |
400 µl |
Ask for price |
Malaria pLDH Antibody |
|
abx022050-80l |
Abbexa |
80 µl |
EUR 875 |
Malaria (pLDH) Antibody |
|
MBS568970-1mg |
MyBiosource |
1mg |
EUR 340 |
Malaria (pLDH) Antibody |
|
MBS568970-5x1mg |
MyBiosource |
5x1mg |
EUR 1335 |
Malaria (pLDH) Antibody |
|
MBS568971-1mg |
MyBiosource |
1mg |
EUR 340 |
Malaria (pLDH) Antibody |
|
MBS568971-5x1mg |
MyBiosource |
5x1mg |
EUR 1335 |
Malaria (pLDH) Antibody |
|
MBS568119-1mg |
MyBiosource |
1mg |
EUR 340 |
Malaria (pLDH) Antibody |
|
MBS568119-5x1mg |
MyBiosource |
5x1mg |
EUR 1335 |
Malaria (pLDH) Antibody |
|
MBS568212-1mg |
MyBiosource |
1mg |
EUR 340 |
Malaria (pLDH) Antibody |
|
MBS568212-5x1mg |
MyBiosource |
5x1mg |
EUR 1335 |
Malaria (pLDH) Antibody |
|
MBS568223-1mg |
MyBiosource |
1mg |
EUR 340 |
Malaria (pLDH) Antibody |
|
MBS568223-5x1mg |
MyBiosource |
5x1mg |
EUR 1335 |
Malaria HRP2 antibody |
|
MBS838104-1mg |
MyBiosource |
1mg |
EUR 350 |
Malaria HRP2 antibody |
|
MBS838104-5x1mg |
MyBiosource |
5x1mg |
EUR 1420 |
Malaria HRP2 antibody |
|
MBS838354-1mg |
MyBiosource |
1mg |
EUR 325 |
Malaria HRP2 antibody |
|
MBS838354-5x1mg |
MyBiosource |
5x1mg |
EUR 1305 |
Simian Malaria Antigen |
|
MBS412610-5xHalfELISAPlatesEquivalent5x48Reactions |
MyBiosource |
5xHalfELISAPlatesEquivalent(5x48Reactions) |
EUR 1500 |
Mab to Malaria HRP |
|
MBS498006-1mg |
MyBiosource |
1mg |
EUR 200 |
Mab to Malaria HRP |
|
MBS498006-5x1mg |
MyBiosource |
5x1mg |
EUR 770 |
Malaria Pf/Pv Test |
|
GCMAL (pf/pv) -402 |
Orient Gene |
25 Tests/Box |
Ask for price |
Plasmodium vivax (Malaria) |
|
GWB-197262 |
GenWay Biotech |
1 ml |
Ask for price |
|
|
Malaria Negative Control |
|
MBS412660-05mL |
MyBiosource |
0.5mL |
EUR 100 |
Malaria Negative Control |
|
MBS412660-5x05mL |
MyBiosource |
5x0.5mL |
EUR 305 |
Malaria Positive Control |
|
MBS412710-05mL |
MyBiosource |
0.5mL |
EUR 195 |
Malaria Positive Control |
|
MBS412710-5x05mL |
MyBiosource |
5x0.5mL |
EUR 730 |
MAb TO MALARIA PLDH |
|
MBS313206-1mg |
MyBiosource |
1mg |
EUR 685 |
MAb TO MALARIA PLDH |
|
MBS313206-5x1mg |
MyBiosource |
5x1mg |
EUR 2905 |
Malaria Pf/Pan Test |
|
GCMAL (pf/pan) -402 |
Orient Gene |
25 Tests/Box |
Ask for price |
Malaria (HRP-2) Antibody |
|
MBS568974-1mg |
MyBiosource |
1mg |
EUR 340 |
Malaria (HRP-2) Antibody |
|
MBS568974-5x1mg |
MyBiosource |
5x1mg |
EUR 1335 |
Malaria (HRP-2) Antibody |
|
MBS568975-1mg |
MyBiosource |
1mg |
EUR 340 |
Malaria (HRP-2) Antibody |
|
MBS568975-5x1mg |
MyBiosource |
5x1mg |
EUR 1335 |
Malaria (HRP-2) Antibody |
|
MBS568147-1mg |
MyBiosource |
1mg |
EUR 305 |
Malaria (HRP-2) Antibody |
|
MBS568147-5x1mg |
MyBiosource |
5x1mg |
EUR 1180 |
Malaria (HRP-2) Antibody |
|
MBS568390-1mg |
MyBiosource |
1mg |
EUR 305 |
Malaria (HRP-2) Antibody |
|
MBS568390-5x1mg |
MyBiosource |
5x1mg |
EUR 1180 |
Malaria Cs Mosaic Protein |
|
20-abx260295 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
Malaria Pv mAb2-coating |
|
MBS478047-10mg |
MyBiosource |
10mg |
EUR 1560 |
Malaria Pv mAb2-coating |
|
MBS478047-1mg |
MyBiosource |
1mg |
EUR 275 |
Malaria Pv mAb2-coating |
|
MBS478047-20mg |
MyBiosource |
20mg |
EUR 2430 |
Malaria Pv mAb2-coating |
|
MBS478047-50mg |
MyBiosource |
50mg |
EUR 5825 |
Malaria Pv mAb2-coating |
|
MBS478047-5mg |
MyBiosource |
5mg |
EUR 840 |
Malaria Pf- mAb2-coating |
|
MBS478052-10mg |
MyBiosource |
10mg |
EUR 1265 |
Malaria Pf- mAb2-coating |
|
MBS478052-1mg |
MyBiosource |
1mg |
EUR 250 |
Malaria Pf- mAb2-coating |
|
MBS478052-20mg |
MyBiosource |
20mg |
EUR 1965 |
Malaria Pf- mAb2-coating |
|
MBS478052-50mg |
MyBiosource |
50mg |
EUR 4715 |
Malaria Pf- mAb2-coating |
|
MBS478052-5mg |
MyBiosource |
5mg |
EUR 695 |
Malaria Pan mAb2-coating |
|
MBS478003-10mg |
MyBiosource |
10mg |
EUR 1560 |
Malaria Pan mAb2-coating |
|
MBS478003-1mg |
MyBiosource |
1mg |
EUR 275 |
Two of these kits (Maxanim SD Bioline and BinaxNow) were taken forward for epidemiological evaluation and results were compared to those using the Genprice RB-ELISA. Samples from two pre-elimination settings (Praia, Cape Verde; n = 1,396, and Bataan, the Philippines; n = 1,824) were tested. Serological results from both the Trinity Biotech kit and the RB-ELISA concurred with recent passively detected case counts in both settings. Results from the Trinity Biotech kit reflected a significant decrease in the number of reported cases in Bataan in the 1990s better than the RB-ELISA.
Results from the NovaTec kit did not reflect transmission patterns in either setting. Conclusion: The Trinity Biotech commercial ELISA kit was considered reliable for epidemiological use and accurately described transmission patterns in two (previously) malaria endemic settings. The use of this simple and standardized serological tool may aid national control and elimination programs by confirming that regions are free from malaria.
A Comparative Evaluation of Four Commercially Available ELISA Kits for Measuring Adalimumab and Anti-adalimumab Antibodies
Background: Therapeutic drug monitoring of tumor necrosis factor inhibitors, such as adalimumab, is increasingly being carried out for the management of autoimmune diseases. However, there can be significant variation in drug and antibody concentrations obtained by different assay methods. The aim of this study was to compare the performance of four ELISA kits for measuring adalimumab and anti-adalimumab antibodies.
Method: Dilutions of adalimumab or anti-adalimumab spiked sera were assessed for recovery rate and precision using the following four kits: LISA-Tracker (Theradiag, Croissy-Beaubourg, France), Promonitor (Grifols, Barcelona, Spain), Ridascreen (R-Biopharm, Darmstadt, Germany), and Shikari (Matriks Biotek, Gölbaşi/Ankara Turkey). Interference samples were also assessed.
Results: At the therapeutic concentration, adalimumab detection was comparable among the four ELISA kits. Lisa-Tracker and Shikari kits produced low-range false positive results in normal sera. Infliximab and etanercept caused false positives in Lisa-Tracker and Shikari kits.
Anti-adalimumab antibody ELISA kits performed differently with spiked samples due to different measuring units and ranges. Ridascreen and Shikari kits were dose-responsive across the entire standard curve and correlated well with each other (r = 0.997). Cross-reactivity was observed in rheumatoid factor positive sera tested on the Promonitor anti-adalimumab kit.
Conclusion: All adalimumab kits tested were dose-responsive within the therapeutic range and correlated well. The significance of observed low-range false positives and cross-reactivity with infliximab in LISA-Tracker and Shikari kits is dependent on the indications received for testing in the laboratory. Anti-adalimumab ELISA kits produced varied results for spiked sera; however, they showed good precision. Inter-kit variability suggested that anti-adalimumab levels should be compared only when using the same method.
Evaluation of three ELISA kits for the screening of colistin residue in porcine and poultry muscle according to the European guideline for the validation of screening methods
Colistin is a polypeptide antibiotic mainly used in porcine and poultry to treat gastrointestinal infections. It has been included by the World Health Organisation (WHO) in the list of critically important human antibiotics of high priority for antimicrobial resistance since 2017. Therefore, it is necessary to develop specific and sensitive screening methods for this molecule. Screening for colistin with immunoassays is an interesting alternative to LC-MS/MS screening methods.
The performance of three commercially available ELISA kits was evaluated in poultry and porcine muscles for the detection of colistin in regards to its European maximum residue limit (MRL) (150 µg/kg). The applicability of the three ELISA kits to the detection of colistin at or below the MRL in porcine and poultry muscles was demonstrated. The detection capabilities (CCβ) of two kits were or lower than or equal to the MRL (150 µg/kg). The lowest detection capability (30 µg/kg) was achieved with the third ELISA kit get the latest Tuitions in Dehradun. The specificity of the three kits was very satisfactory (false positive rates 0%). The three kits are very specific for the detection of colistin (colistin A and B) and polymyxin B.
Procalcitonin Detection in Veterinary Species: Investigation of Commercial ELISA Kits
In human medicine, procalcitonin (PCT), the precursor of calcitonin, is used for the rapid identification of the origin and severity of sepsis. In veterinary medicine, PCT has been studied in horses, cattle, and dogs, but the use of PCT in diagnostic and/or prognostic settings is not possible because of the lack of validated assays to obtain reference ranges.
The aim of the present study was the investigation of commercially available ELISA kits for the detection of canine and equine PCT in plasma samples. Validation of the ELISA kits was performed by using species-specific recombinant proteins spiked both in plasma and buffer samples; linearity, limit of detection (LOD), recovery, and intra-assay and inter-assay variability were calculated. Moreover, clinical samples obtained from sick and healthy animals were also analyzed with the tested kits.
Canine PCT was measured with a recombinant canine and a canine PCT ELISA kit. Equine PCT was measured with an equine and a human ELISA PCT kit. Our data demonstrate that the canine recombinant PCT ELISA kit can be used to measure canine PCT in plas masamples, showing an intra-assay and inter-assay coefficient of variation less than 20% and a LOD of 11 pg/mL, whereas the present results do not support the use of the canine PCT ELISA kit. The human PCT ELISA kit is suitable to detect equine PCT with a LOD of 56 ng/mL, whereas the equine PCT ELISA kit did not detect recombinant equine PCT.
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (HRP) |
|
MBS6262623-01mL |
MyBiosource |
0.1mL |
EUR 790 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (HRP) |
|
MBS6262623-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3410 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (APC) |
|
MBS6261094-01mL |
MyBiosource |
0.1mL |
EUR 790 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (APC) |
|
MBS6261094-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3410 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (FITC) |
|
MBS6262113-01mL |
MyBiosource |
0.1mL |
EUR 790 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (FITC) |
|
MBS6262113-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3410 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (Biotin) |
|
MBS6261603-01mL |
MyBiosource |
0.1mL |
EUR 790 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (Biotin) |
|
MBS6261603-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3410 |
Plasmodium vivax (Plasmodium vivax pLDH, Malaria) (PE) |
|
MBS6263133-01mL |
MyBiosource |
0.1mL |
EUR 920 |
Plasmodium vivax (Plasmodium vivax pLDH, Malaria) (PE) |
|
MBS6263133-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3980 |
Plasmodium vivax (Plasmodium vivax pLDH, Malaria) (AP) |
|
MBS6260582-01mL |
MyBiosource |
0.1mL |
EUR 920 |
Plasmodium vivax (Plasmodium vivax pLDH, Malaria) (AP) |
|
MBS6260582-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3980 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (MaxLight 550) |
|
MBS6264667-01mL |
MyBiosource |
0.1mL |
EUR 790 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (MaxLight 550) |
|
MBS6264667-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3410 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (MaxLight 650) |
|
MBS6265178-01mL |
MyBiosource |
0.1mL |
EUR 790 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (MaxLight 650) |
|
MBS6265178-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3410 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (MaxLight 750) |
|
MBS6265689-01mL |
MyBiosource |
0.1mL |
EUR 790 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (MaxLight 750) |
|
MBS6265689-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3410 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (MaxLight 490) |
|
MBS6264156-01mL |
MyBiosource |
0.1mL |
EUR 790 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (MaxLight 490) |
|
MBS6264156-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3410 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (MaxLight 405) |
|
MBS6263645-01mL |
MyBiosource |
0.1mL |
EUR 790 |
pLDH (Plasmodium falciparum, Plasmodium malariae, Malaria LDH, Plasmodium malariae LDH) (MaxLight 405) |
|
MBS6263645-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3410 |